Provided by Tiger Trade Technology Pte. Ltd.

ZHAOKE OPHTH-B

2.550
-0.030-1.16%
Volume:100.00K
Turnover:259.44K
Market Cap:1.40B
PE:-6.67
High:2.630
Open:2.580
Low:2.550
Close:2.580
52wk High:4.280
52wk Low:2.380
Shares:549.00M
HK Float Shares:549.00M
Volume Ratio:0.58
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.382
ROE:-13.89%
ROA:-8.82%
PB:0.86
PE(LYR):-6.67
PS:34.28

Loading ...

China's Angelalign H1 Revenue Rises on Higher Clear Aligner Case Volume

Reuters
·
Yesterday

Hong Kong's Lee's Pharmaceutical H1 Profit Jumps on Higher-Margin Product Sales

Reuters
·
Yesterday

Lee's Pharm Reports 41.4% Profit Surge in H1 Results

Stock News
·
Yesterday

China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth

Reuters
·
Yesterday

Zhaoke Ophthalmology (SEHK:6622) Stock Carries A 34.7x P/S Under Heavy Losses

Simply Wall St.
·
Yesterday

Zhaoke Ophthalmology's Half-Year Results: Net Loss Widens to RMB 123 Million Amid Rising Costs

Stock News
·
Aug 28

China's Ocumension Therapeutics H1 Revenue Surges on Higher Ophthalmic Product Sales

Reuters
·
Aug 28

China's Zhaoke Ophthalmology H1 Revenue Rises

Reuters
·
Aug 28

Zhaoke Ophthalmology FY26 H1 Loss Widens to RMB 122.59 Million; Revenue Rises 19.14% to RMB 18.83 Million

Reuters
·
Aug 28

Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve

Stock News
·
Aug 26

Hong Kong Stock Movers: Lee's Pharm Surges Over 7% After ZK2401 IND Accepted by China's NMPA

Stock News
·
Aug 14

Zhaoke Ophthalmology Enters 5-Year Exclusive Mainland China Distribution Agreement with Pharmentum Biopharma for Epinastine Eye Drops

Bulletin Express
·
Aug 12

Zhaoke Ophthalmology Signs Exclusive Distribution Deal with Pharmentum Biopharma for Epinastine Eye Drops in China

Reuters
·
Aug 12

Zhaoke Ophthalmology - Enters Exclusive Distribution Agreement with Pharmentum Biopharma in China

THOMSON REUTERS
·
Aug 12

Zhaoke Ophthalmology - Agreement to Commercialize Epinastine Hydrochloride Eye Drops in China (Excluding Hong Kong, Macau and Taiwan)

THOMSON REUTERS
·
Aug 12

Zhaoke Ophthalmology: No Change in Issued Shares for July 2026; 66.50 k Shares Await Cancellation After Buy-back

Bulletin Express
·
Aug 03

Zhaoke Ophthalmology secures Macau clearance for innovative presbyopia therapy YUVEZZI™

Bulletin Express
·
Jul 20

Innovative Presbyopia Treatment YUVEZZI™ from Zhaoke Ophthalmology Receives Approval in Macau

Stock News
·
Jul 20

Zhaoke Ophthalmology - Yuvezzitm Approved by Macau Pharmaceutical Administration Bureau for Presbyopia Treatment

THOMSON REUTERS
·
Jul 20

Zhaoke Ophthalmology Says Macau Regulator Approves Presbyopia Eye Drop Yuvezzi

Reuters
·
Jul 20